Solventum (NYSE: SOLV) announced today that it has achieved the Diamond Level Resiliency Badge from the Healthcare Industry ...

The company announced the launch of its Supply Assurance Program, which guarantees 45 days of inventory on hand at "key distributor warehouse locations." ...

First-of-its-Kind Offering: No additional cost, no contracts required for customers. Comprehensive Coverage: Comprises B. Braun’s full product portfolio, including the complete line of products not ...

YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced ...

Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...

Discusses Oncology Pipeline Advances and Phase III Clinical Updates at Science and Technology Day December 15, ...

Vyriad, Inc., a clinical-stage biotechnology company developing targeted genetic therapies for cancer and other serious diseases, presented detailed data on its lentiviral vector retargeting ...

Access to cancer care in India is hindered by late diagnoses and a lack of specialised facilities. Efforts are underway to ...

Spiral, the award-winning platform redefining personalized banking, today announced a partnership with Lake City Bank, a leading Indiana-based bank. The partnership provides Lake City Bank with a ...

Detailed price information for Sutro Biopharma Inc (STRO-Q) from The Globe and Mail including charting and trades.

Creative Biolabs optimizes the mRNA drug development model by integrating sequence design, RNA-protein interaction ...

ADEL Inc., a biopharma company, has entered into an exclusive worldwide license agreement with Sanofi for the development and ...